Interferon Regulatory Factors: Where to Stand in Transplantation

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Interferon Regulatory Factors: Where to Stand in Transplantation Publisher Pubmed

Assadiasl S¹ ; Shahi A² ; Salehi S² ; Afzali S² ; Amirzargar A^{1, 2}

Source: Transplant Immunology Published:2018

Abstract

Interferon regulatory factors (IRFs) are implicated in regulating inflammatory responses to pathogens and alloantigens. Since transplantation is usually accompanied by ischemia reperfusion injury (IRI), acute and chronic rejections, as well as immunodeficiency due to immunosuppressive drugs, IRFs seem to play a considerable role in allograft outcome. For instance, IRF-1 has been shown to be involved in pathogenesis of IRI; however, IRF-2 exhibits an opposite function. Some IRF-3 and 5 SNPs are associated with better or worse graft survival rates. Of note, IRF-4 inhibition has resulted in improved transplant outcomes. Herein we review available studies about IRFs influence on various stages of transplantation. © 2018 Elsevier B.V.

Related Docs

View other Related Docs

1. Comparing Irf-4 Gene Expression Between Acute T Cell-Mediated Rejection and Stable Renal Transplant Recipients, Iranian Journal of Kidney Diseases (2021)

2. Expression of Programmed Cell Death 1 and Helios Genes Correlates With Rs872071a>G and Rs12203592c>T Single-Nucleotide Polymorphisms of Interferon Regulatory Factor 4 in Patients With T-Cell-Mediated Rejection of Renal Allograft, Experimental and Clinical Transplantation (2022)

3. Toll-Like Receptor 4 in Renal Transplant, Experimental and Clinical Transplantation (2018)

Experts (# of related papers)

View all Related Experts

Ali Akbar Amirzargar (8)

Mohammad Hossein Nicknam (8)

Other Related Docs

4. Tlr-2, Tlr-4 and Myd88 Genes Expression in Renal Transplant Acute and Chronic Rejections, International Journal of Immunogenetics (2019)

5. Increased Expression of Toll-Like Receptors 2 and 4 in Renal Transplant Recipients That Develop Allograft Dysfunction: A Cohort Study, Iranian Journal of Immunology (2017)

6. Cytokines in Liver Transplantation, Cytokine (2021)

7. Association of Interferon Regulatory Factor 5 (Irf5) Gene Polymorphisms With Juvenile Idiopathic Arthritis, Clinical Rheumatology (2018)

8. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside, Iranian Journal of Kidney Diseases (2019)

9. Frequency of Dendritic Cell Subsets and Ilt3, Ilt4 Gene Expression in Two Different Immunosuppressive Protocols in Kidney Transplant Recipients. a Cohort Report, Molecular Biology Reports (2020)

10. Potential Roles of Long Noncoding Rnas As Therapeutic Targets in Organ Transplantation, Frontiers in Immunology (2022)

11. Nlrp3 Inflammasome: Significance and Potential Therapeutic Targets to Advance Solid Organ Transplantation, Expert Opinion on Therapeutic Targets (2025)

12. Preventing the Rejection of Skin Allografts by Immunomodulatory and Regenerative Effects of Exosomes Derived From Bone Marrow Mesenchymal Stem Cells in Mice, Iranian Journal of Basic Medical Sciences (2025)

13. Interferons: Role in Cancer Therapy, Immunotherapy (2020)

14. Innate Inflammatory Gene Expression Profiling in Potential Brain-Dead Donors: Detailed Investigation of the Effect of Common Corticosteroid Therapy, Innate Immunity (2017)

15. Expression Patterns of Toll Like Receptor (Tlr)-2, Tlr-4 and Myeloid Differentiation Primary Response Gene 88 (Myd88) in Renal Transplant Patients Developing Allograft Dysfunction; a Cohort Study, Transplant Immunology (2018)

16. Effect of Hypertonic Saline 5% on Early Graft Function and Urinary Interleukin 18 and Neutrophil Gelatinase-Associated Lipocalin in Deceased-Donor Kidney Transplantation, Iranian Journal of Pharmaceutical Research (2017)

17. Intestinal Transplantation: Significance of Immune Responses, Arab Journal of Gastroenterology (2024)

18. Altered Expression of Micrornas Following Chronic Allograft Dysfunction With Interstitial Fibrosis and Tubular Atrophy, Iranian Journal of Allergy# Asthma and Immunology (2015)

19. Cell Therapy in Transplantation: A Comprehensive Review of the Current Applications of Cell Therapy in Transplant Patients With the Focus on Tregs, Car Tregs, and Mesenchymal Stem Cells, International Immunopharmacology (2021)

20. T Helper-9 Cells and Interleukin-9 in Transplantation: The Open Question, Human Immunology (2022)

Style	Citing Format
MLA	Assadiasl S, et al.. "Interferon Regulatory Factors: Where to Stand in Transplantation." Transplant Immunology, vol. 51, no. , 2018, pp. 76-80.
APA	Assadiasl S, Shahi A, Salehi S, Afzali S, Amirzargar A (2018). Interferon Regulatory Factors: Where to Stand in Transplantation. Transplant Immunology, 51(), 76-80.
Chicago	Assadiasl S, Shahi A, Salehi S, Afzali S, Amirzargar A. "Interferon Regulatory Factors: Where to Stand in Transplantation." Transplant Immunology 51, no. (2018): 76-80.
Harvard	Assadiasl S et al. (2018) 'Interferon Regulatory Factors: Where to Stand in Transplantation', Transplant Immunology, 51(), pp. 76-80.
Vancouver	Assadiasl S, Shahi A, Salehi S, Afzali S, Amirzargar A. Interferon Regulatory Factors: Where to Stand in Transplantation. Transplant Immunology. 2018;51():76-80.
BibTex	@article{ author = {Assadiasl S and Shahi A and Salehi S and Afzali S and Amirzargar A}, title = {Interferon Regulatory Factors: Where to Stand in Transplantation}, journal = {Transplant Immunology}, volume = {51}, number = {}, pages = {76-80}, year = {2018} }
RIS	TY - JOUR AU - Assadiasl S AU - Shahi A AU - Salehi S AU - Afzali S AU - Amirzargar A TI - Interferon Regulatory Factors: Where to Stand in Transplantation JO - Transplant Immunology VL - 51 IS - SP - 76 EP - 80 PY - 2018 ER -

Science Communicator Platform

Authors

Abstract